Clinical Trials Directory

Trials / Completed

CompletedNCT05831267

Fibrin Glue Versus Titanium Platelet-rich Fibrin in Lateral Sinus Lifting

Fibrin Glue Versus Titanium Platelet-rich Fibrin as a Sole Filling Material in Lateral Sinus Lifting With Simultaneous Implant Placement (Randomized Controlled Clinical Trial )

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Hams Hamed Abdelrahman · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Graftless sinus lift with simultaneous implant placement is one of the new techniques, this new technique is presented based on the physiology of intrasinus bone repair. Schneiderian membrane is known to have an osteogenic nature, now blood clot can be considered autologous osteogenic graft material, to which osteoprogenitors can migrate, differentiate, and regenerate bone. The aim of this study is to evaluate the effectiveness of using Fibrin glue versus Titanium platelet rich fibrin (T-PRF) as a sole filling material in lateral sinus lifting using with simultaneous implant placement in comparison to a negative control group.

Conditions

Interventions

TypeNameDescription
OTHERFibrin GlueBlood samples were collected from the antecubital vein of the right or left arm of the patient and drawn into sterile Titanium tubes immediately. The tubes were then centrifuged for 12 minutes at 2800 rpm and room temperature
OTHERT-PRFThe contents of the two containers (human fibrinogen, human thrombin) will be mixed with distilled water and then aspirated by two syringes after that, the two solutions will be mixed together and injected into the empty compartment around the dental implant under the sinus mucosal lining using auto mixing applicator.
OTHERNegative controlthis group will not receive any material.

Timeline

Start date
2022-02-01
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2023-04-26
Last updated
2023-04-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05831267. Inclusion in this directory is not an endorsement.